Typical timeline
6–12 months
Includes QMS build-out plus Stage 1/Stage 2 certification audits; organizations with an existing quality system can move faster.
International Standard
The international quality management system standard specific to medical device manufacturers, referenced by most major regulators.
Overview
ISO 13485 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements. It underpins CE Marking, is required for Health Canada licensing, and is referenced by FDA's Quality Management System Regulation (QMSR).
Requirements
The documentation and evidence a complete submission is normally built from.
Planning ranges
Ranges illustrate general market patterns for this pathway — they are not a quote for a specific product.
Typical timeline
6–12 months
Includes QMS build-out plus Stage 1/Stage 2 certification audits; organizations with an existing quality system can move faster.
Estimated cost
$8k–$40k
Varies by company size, number of sites, and certification body; figure includes consulting, internal audit prep, and the 3-year certification cycle.
Timelines and costs above are typical ranges illustrating general market patterns, not a quote or regulatory conclusion for your specific product. Actual figures depend on device classification, target country, and applicant readiness — professional review is required before relying on this for a business decision.
Where this applies
Jurisdictions that recognise this certification. Scope and conditions still vary by product classification.
Related
FAQ
It's mandatory in some jurisdictions (e.g. Canada, via MDSAP) and a practical prerequisite in others (EU MDR compliance is very difficult without it) even where not literally required by name.
ISO 13485 is medical-device-specific, adding requirements around risk management, traceability, and regulatory compliance that general-purpose ISO 9001 does not include.
Related
The conformity mark required to sell medical devices in the EU/EEA, issued once a device meets EU MDR or IVDR requirements.
View →
US market authorization for medical devices via the FDA's 510(k), De Novo, or PMA pathways.
View →
The manufacturing quality framework underlying most device and pharmaceutical regulatory approvals worldwide.
View →
Reviewed packages
Buy a defined outcome
Market Entry Sprint from $2,500 · Strategy Session $500 · Pathway Brief $1,800. Professional review required before business use. No patient data on public forms.
Reviewed launch planning
ISO 13485 pathway briefs start at $1,800. Or book a $2,500 Market Entry Sprint that includes regulatory pathway outline, evidence flags, and a review call.
Professional review is required before business use.